CD276 and colorectal cancer: Using 1 μg/mL anti–B7-H3 mAb, we were unable to explain the differential susceptibility of colorectal cancer PDOs to ADCC based on the stIL15-γδ T %CD16 expression either after manufacture or at the experiment endpoint (Supplementary Fig. S7A, S7E, and S7F).